NGS in advanced breast cancer: exploring recent clinical advancements

Learn how NGS is guiding breast cancer management today. Explore the potential utility of complementary solid tumor and liquid biopsy testing in informing treatment decisions, as well as patient management strategies in the post CDK4/6 inhibitor therapy setting.

Q&A: De-risking clinical trials with real-world data

View the Tempus vision.

We’re looking for people who can change the world.